课题基金 / 基金详情

COMBINED SODIUM FLUORIDE AMP; CALCIUM CITRATE THERAPY IN OSTEOPOROSIS

COMBINED SODIUM FLUORIDE AMP; CALCIUM CITRATE THERAPY IN OSTEOPOROSIS
组合氟化钠放大器;
批准号:
7606303
负责人:
KHASHAYAR SAKHAEE
金额:
$0.29万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2007-09-16

项目摘要

项目成果

KHASHAYAR SAKHAEE的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this project is to determine whether or not the amount of bone in persons suffering from osteoporosis can be increased using a combination treatment program utilizing slow-release sodium fluoride and calcium citrate. Since this is a non-randomized study, only previously entered patients continue to be studied.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenesis of Idiopathic Uric Acid Nephrolithiasis: The Role of Renal Lipotoxic
  • 批准号:
    7812212
  • 项目类别:
  • 资助金额:
    $37.3万
  • 财政年份:
    2009
  • 负责人:
    KHASHAYAR SAKHAEE
  • 依托单位:
Pathogenesis of Idiopathic Uric Acid Nephrolithiasis: The Role of Renal Lipotoxic
  • 批准号:
    8072745
  • 项目类别:
  • 资助金额:
    $33.47万
  • 财政年份:
    2009
  • 负责人:
    KHASHAYAR SAKHAEE
  • 依托单位:
Pathogenesis of Idiopathic Uric Acid Nephrolithiasis and Renal Lipotoxicity
  • 批准号:
    8271447
  • 项目类别:
  • 资助金额:
    $33.47万
  • 财政年份:
    2009
  • 负责人:
    KHASHAYAR SAKHAEE
  • 依托单位:
Pathogenesis of Idiopathic Uric Acid Nephrolithiasis: The Role of Renal Lipotoxic
  • 批准号:
    7653921
  • 项目类别:
  • 资助金额:
    $37.68万
  • 财政年份:
    2009
  • 负责人:
    KHASHAYAR SAKHAEE
  • 依托单位: